Latest

US FDA approves new Chinese drug in the treatment of aggressive cancer

2023-11-06

Shanghai Junshi Biosciences has gained approval from the United States' Food and Drug Administration for a market launch of a flagship self-developed cancer treatment, which experts said marks another milestone of domestic enterprises' innovation and production capacities.
Art to give cultural touch to sixth CIIE

2023-11-02

Thanks to duty-free policy, 135 pieces of art valued at more than 1 billion yuan ($136 million) will vie with products, brands, services, technologies and content for the limelight at the upcoming sixth China International Import Expo in Shanghai.
3rd Yangtze River Delta industrial development and cooperation forum held in Pudong

2023-10-26

An industrial development and cooperation forum was recently held in Pudong New Area.
Lujiazui Financial City hosts Saudi Arabia promotional meeting

2023-10-24

A Saudi investment environment promotion and docking meeting for Lujiazui Financial City enterprises was held at the Shanghai Center on Oct 19.
Firms bullish on scope of China market

2023-10-24

Multinational enterprises are unwaveringly committed to the Chinese market and will keep investing in China, as the country's pursuit of high-quality development and Chinese modernization are set to offer them more development opportunities.
Shanghai FTZ targets first-class business environment

2023-10-19

Over the past decade, the China (Shanghai) Pilot Free Trade Zone has been ramping up efforts to promote the transformation of government functions and build a market-oriented, rule of law-based and internationalized business environment through institutional innovation.
Zhangjiang leads the development of synthetic biology

2023-10-19

From applications to industrial platforms, from basic enabling technologies to source technologies, Zhangjiang in Shanghai's Pudong New Area possesses concentrated and highly visible first-mover advantages.
Biomedical industry revenue in bonded area exceeds 200 billion yuan from January to August

2023-10-16

From January to August, the biomedical industry in the bonded area of the China (Shanghai) Pilot Free Trade Zone achieved a business income of 203.7 billion yuan ($27.86 billion).

< 1 ... 18 19 20 21 22 ... 142 >

What's New